BioCatalystWatch
VRCAWorkspace / VRCA / OverviewCompany library
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. (VRCA)

Website

Price
Market cap
Next catalystExpected Q1 2027YCANTH (VP-102) — COVE-2 · Phase 3 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

VP-102 (YCANTH)

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VP-102 (YCANTH)

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

YCANTH (VP-102) topical solution

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VRCA PR & News

PR & News

VRCA SEC archive